- Home
- GOVX vs NAAS Comparison
GOVX vs NAAS Comparison
Compare GOVX & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- NAAS
- Stock Information
- Founded
- GOVX 2001
- NAAS 2019
- Country
- GOVX United States
- NAAS China
- Employees
- GOVX N/A
- NAAS N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- NAAS Other Specialty Stores
- Sector
- GOVX Health Care
- NAAS Consumer Discretionary
- Exchange
- GOVX Nasdaq
- NAAS Nasdaq
- Market Cap
- GOVX 7.6M
- NAAS 8.3M
- IPO Year
- GOVX N/A
- NAAS 2017
- Fundamental
- Price
- GOVX $0.75
- NAAS $0.60
- Analyst Decision
- GOVX Strong Buy
- NAAS
- Analyst Count
- GOVX 4
- NAAS 0
- Target Price
- GOVX $10.50
- NAAS N/A
- AVG Volume (30 Days)
- GOVX 2.7M
- NAAS 1.7M
- Earning Date
- GOVX 08-05-2025
- NAAS 07-29-2025
- Dividend Yield
- GOVX N/A
- NAAS N/A
- EPS Growth
- GOVX N/A
- NAAS N/A
- EPS
- GOVX N/A
- NAAS N/A
- Revenue
- GOVX $5,591,576.00
- NAAS $27,534,354.00
- Revenue This Year
- GOVX N/A
- NAAS $378.49
- Revenue Next Year
- GOVX N/A
- NAAS N/A
- P/E Ratio
- GOVX N/A
- NAAS N/A
- Revenue Growth
- GOVX N/A
- NAAS N/A
- 52 Week Low
- GOVX $0.43
- NAAS $0.49
- 52 Week High
- GOVX $11.18
- NAAS $41.80
- Technical
- Relative Strength Index (RSI)
- GOVX 47.67
- NAAS 30.33
- Support Level
- GOVX $0.60
- NAAS $0.49
- Resistance Level
- GOVX $0.76
- NAAS $0.60
- Average True Range (ATR)
- GOVX 0.08
- NAAS 0.07
- MACD
- GOVX 0.02
- NAAS -0.01
- Stochastic Oscillator
- GOVX 59.45
- NAAS 24.90
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.